EBV related cerebral lymphoma in a leukemia patient treated with alemtuzumab

MeSH terms

• Alemtuzumab
• Antibodies, Monoclonal / adverse effects*
• Antibodies, Monoclonal, Humanized
• Antibodies, Neoplasm / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Brain Neoplasms / pathology
• Brain Neoplasms / virology*
• Cyclophosphamide / therapeutic use
• Epstein-Barr Virus Infections / complications*
• Epstein-Barr Virus Infections / pathology
• Herpesvirus 4, Human
• Humans
• Immune System / drug effects
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
• Leukemia, Lymphocytic, Chronic, B-Cell / pathology
• Lymphoma, Large B-Cell, Diffuse / pathology
• Lymphoma, Large B-Cell, Diffuse / virology*
• Male
• Middle Aged
• Neoplasms, Second Primary / pathology
• Neoplasms, Second Primary / virology*
• Vidarabine / analogs & derivatives
• Vidarabine / therapeutic use